These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3284700)

  • 1. Modulation of T-cell-mediated regulation of antibody production by interaction with specific immune complexes.
    Clough JD; Calabrese LH; Budervic SA
    Clin Lab Med; 1988 Jun; 8(2):337-49. PubMed ID: 3284700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human platelet-immune complex interaction in plasma.
    Clark WF; Tevaarwerk GJ; Reid BD
    J Lab Clin Med; 1982 Dec; 100(6):917-31. PubMed ID: 6982951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phagocytosis and degradation of DNA-anti-DNA complexes by human phagocytes: influence of the antibody class.
    Lamers MC; de Groot ER; Roos D
    Lab Invest; 1982 Apr; 46(4):393-9. PubMed ID: 7070053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunochemical determination of DNA in immune complexes present in the circulation of patients with systemic lupus erythematosus.
    Nezlin R; Alarcón-Segovia D; Shoenfeld Y
    J Autoimmun; 1998 Oct; 11(5):489-93. PubMed ID: 9802934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune complex-dependent T cell-mediated cytostasis (IDTC).
    Tanaka J; Yata J
    Clin Exp Immunol; 1981 Jul; 45(1):215-23. PubMed ID: 6975682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of T cell subtyping to distinguish rheumatoid arthritis from systemic lupus erythematosus.
    Traycoff RB; Rogers WW; Gregory SA
    J Rheumatol; 1981; 8(3):494-7. PubMed ID: 6974781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoregulation by antigen/antibody complexes. I. Specific immunosuppression induced in vivo with immune complexes formed in antibody excess.
    Caulfield MJ; Shaffer D
    J Immunol; 1987 Jun; 138(11):3680-3. PubMed ID: 3584970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune complexes--pathogenetic factors of autoimmune systemic lupus erythematosus.
    Wollina U
    Allerg Immunol (Leipz); 1984; 30(1):3-13. PubMed ID: 6233860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of reticuloendothelial system function in man using receptor-specific probes.
    Hamburger MI
    Neth J Med; 1984; 27(9):359-67. PubMed ID: 6239984
    [No Abstract]   [Full Text] [Related]  

  • 10. Modulation of the humoral immune response by antibody-mediated antigen targeting to complement receptors and Fc receptors.
    Baiu DC; Prechl J; Tchorbanov A; Molina HD; Erdei A; Sulica A; Capel PJ; Hazenbos WL
    J Immunol; 1999 Mar; 162(6):3125-30. PubMed ID: 10092761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fc-receptors for IgG and IgM immunoglobulins on human T lymphocytes: mode of re-expression after proteolysis or interaction with immune complexes.
    Mingari MC; Moretta L; Moretta A; Ferrarini M; Preud'homme JL
    J Immunol; 1978 Aug; 121(2):767-70. PubMed ID: 308080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating immune complexes (CIC) in connective tissue diseases (CTD).
    Schrieber L; Maini RN
    Neth J Med; 1984; 27(9):327-39. PubMed ID: 6239983
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulation and targeting of T-cell immune responses by IgE and IgG antibodies.
    Bheekha Escura R; Wasserbauer E; Hammerschmid F; Pearce A; Kidd P; Mudde GC
    Immunology; 1995 Nov; 86(3):343-50. PubMed ID: 8550069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and cellular basis of anti-DNA antibody synthesis in systemic lupus erythematosus of New Zealand mice.
    Shirai T; Hirose S; Sekigawa I; Okada T; Sato H
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():11-20. PubMed ID: 3497267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for an immune complex disorder in systemic lupus erythematosus (SLE).
    McCluskey RT
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):119-25. PubMed ID: 6213147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
    Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
    Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defects in the regulation of anti-DNA antibody production in aged lupus-prone (NZB x NZW)F1 mice: analysis of T-cell lymphokine synthesis.
    Sato MN; Minoprio P; Avrameas S; Ternynck T
    Immunology; 1995 May; 85(1):26-32. PubMed ID: 7635519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fc receptors for mouse IgG1 on human monocytes: polymorphism and role in antibody-induced T cell proliferation.
    Tax WJ; Hermes FF; Willems RW; Capel PJ; Koene RA
    J Immunol; 1984 Sep; 133(3):1185-9. PubMed ID: 6235283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating DNA-anti-DNA complexes in lupus nephritis and idiopathic nephritis.
    Williams DG; Adu D
    Proc Eur Dial Transplant Assoc; 1980; 17():629-36. PubMed ID: 6787585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody and immune complexes induce tissue factor production by human endothelial cells.
    Tannenbaum SH; Finko R; Cines DB
    J Immunol; 1986 Sep; 137(5):1532-7. PubMed ID: 3745915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.